Stockscreener 앱 받기
41.88
2.60%
1.06
시간 외 거래:
40.90
-0.98
-2.34%
전일 마감가:
$40.82
열려 있는:
$42.28
하루 거래량:
69.96M
Relative Volume:
2.46
시가총액:
$6.37B
수익:
$1.24B
순이익/손실:
$101.26M
주가수익비율:
95.18
EPS:
0.44
순현금흐름:
$149.62M
1주 성능:
+47.05%
1개월 성능:
+61.14%
6개월 성능:
+102.91%
1년 성능:
+271.94%
1일 변동 폭
$39.80
$43.10
1주일 범위
$31.75
$43.10
52주 변동 폭
$11.45
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
명칭
Hims Hers Health Inc
전화
415-851-0195
주소
2269 CHESTNUT ST, SAN FRANCISCO
HIMS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
41.88 | 6.37B | 1.24B | 101.26M | 149.62M | 0.44 |
|
PG
Procter Gamble Co
|
158.83 | 379.46B | 83.93B | 15.50B | 15.03B | 6.30 |
|
UL
Unilever Plc Adr
|
63.47 | 160.71B | 65.10B | 6.16B | 0 | 2.4569 |
|
CL
Colgate Palmolive Co
|
90.74 | 77.71B | 19.95B | 2.90B | 3.47B | 3.54 |
|
KVUE
Kenvue Inc
|
23.64 | 44.34B | 15.46B | 1.03B | 1.34B | 0.53 |
|
KMB
Kimberly Clark Corp
|
130.90 | 43.43B | 19.75B | 2.47B | 2.39B | 7.34 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-29 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-02-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2025-01-07 | 개시 | BTIG Research | Buy |
| 2024-12-17 | 개시 | Morgan Stanley | Overweight |
| 2024-11-14 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2024-08-22 | 개시 | Needham | Buy |
| 2024-08-09 | 다운그레이드 | Imperial Capital | Outperform → In-line |
| 2024-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-04-16 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-04-10 | 개시 | Canaccord Genuity | Buy |
| 2024-02-28 | 업그레이드 | Imperial Capital | In-line → Outperform |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2023-12-07 | 개시 | Imperial Capital | In-line |
| 2023-07-28 | 개시 | TD Cowen | Outperform |
| 2023-04-11 | 개시 | Robert W. Baird | Neutral |
| 2023-02-09 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-11-08 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-11-08 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | 개시 | Truist | Hold |
| 2022-07-15 | 개시 | SVB Leerink | Underperform |
| 2022-04-14 | 개시 | Guggenheim | Buy |
| 2022-04-01 | 재개 | Credit Suisse | Outperform |
| 2022-03-10 | 개시 | Deutsche Bank | Hold |
| 2021-12-02 | 개시 | Jefferies | Hold |
| 2021-11-11 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | 개시 | BofA Securities | Neutral |
| 2021-05-20 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | 개시 | Truist | Hold |
| 2021-03-09 | 개시 | Credit Suisse | Neutral |
| 2021-03-02 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-02-17 | 개시 | Citigroup | Neutral |
| 2021-02-12 | 개시 | Piper Sandler | Neutral |
| 2021-02-08 | 개시 | Tigress Financial | Buy |
모두보기
Hims Hers Health Inc 주식(HIMS)의 최신 뉴스
Hims & Hers Health Revenue Jumps, But Outlook Disappoints - WSJ
Hims & Hers Health Q1 Earnings, Revenue Rise - marketscreener.com
Hims & Hers stock slips on disappointing Q2 revenue outlook - Yahoo Finance
Hims & Hers Health Stock: What’s Driving the Drop? - TipRanks
Hims Hers Health earnings missed by $0.03, revenue topped estimates - Investing.com UK
Hims & Hers Health, Inc. SEC 10-Q Report - TradingView
Hims & Hers Health shares drop on earnings miss, mixed outlook - Investing.com Canada
Hims Earnings Reveal Massive 111% Growth as Digital Health Platform Targets $6.5B Revenue by 2030 - Stock Titan
Leerink keeps Hims & Hers stock at Market Perform, $40 target - Investing.com India
Buffett succession, Palantir earnings preview, Hims COO pick - Yahoo Finance
BofA maintains HIMS stock Underperform rating and $26 target By Investing.com - Investing.com India
Hims Taps Amazon Vet to Lead Operations as Company Expands - Bloomberg.com
Hims & Hers (NYSE: HIMS) Live: Complete Earnings Coverage - AOL.com
Hims & Hers: The Next Amazon? Novo Nordisk Might Be Prime Delivery - Benzinga
Hims & Hers appoints Amazon veteran as COO - Sherwood News
Hims & Hers Appoints Global Operations Expert and Amazon Veteran as Chief Operations Officer - BioSpace
Hims & Hers Stock Rally (NYSE: HIMS) Faces Up to Earnings – What Next? - AskTraders.com
Hims & Hers Health Names Nader Kabbani COO - marketscreener.com
Hims & Hers appoints former Amazon executive as COO - Investing.com
Hims & Hers (NYSE: HIMS) Earnings Are In (Live Coverage) - 24/7 Wall St.
Hims & Hers short interest at critical levels after best weekly gain: report - MSN
Hims & Hers Health Q1 2025 Earnings Preview - MSN
Why Hims & Hers Health, Inc. (HIMS) Soared Last Week? - Yahoo Finance
Hims & Hers Health Earnings: What To Look For From HIMS - FinancialContent
HIMS Faces Potential Short Squeeze Amid Recent Stock Surge - GuruFocus
Hims & Hers stock gains risking short squeeze (HIMS:NYSE) - Seeking Alpha
Hims & Hers Stock Surges on Wegovy Deal With Novo Nordisk - MSN
Why Hims & Hers Health, Inc. (HIMS) Went Up On Friday - Insider Monkey
Hims & Hers stock price soars after partnership with Novo Nordisk to offer weight-loss drug Wegovy - MSN
Hims & Hers Health (HIMS) Stock Surges 10%: What’s Behind the Rally? - paginasiete.bo
HIMS Stock Rises 24% After Partnering with Novo Nordisk - GuruFocus
Can Sustained Product Demand Drive HIMS Stock Before Q1 Earnings? - Nasdaq
Hims & Hers Stock Soars on Novo Nordisk Collaboration - MSN
Rx Rundown: Merck KGaA, Novartis, Hims & Hers and more - Medical Marketing and Media
Novo Nordisk Teams With Telehealth Firms Him, Ro to Sell Wegovy at Lower Price - MSN
Hims & Hers Health, Inc. (HIMS) May 9 weekly 36.50 straddle priced into quarter results - StreetInsider
Learn to Evaluate (HIMS) using the Charts - news.stocktradersdaily.com
Why Hims & Hers Health, Inc. (HIMS) Soared On Thursday - Yahoo Finance
10 Firms Lead Rally on Impressive Q1 Earnings, Optimistic Outlooks - Insider Monkey
You might soon be able to get Wegovy from an online shop — here is where you need to visit - AOL.com
Hims & Hers Health (NYSE:HIMS) Surges 24% In One Week After Novo Nordisk Partnership - Yahoo Finance
CVS Caremark To Place Novo Nordisk's Wegovy On Preferred Coverage For GLP-1 Weight Loss Treatment - Benzinga
Hims & Hers: Revolutionizing Healthcare (NYSE:HIMS) - Seeking Alpha
How To Trade Hims & Hers Health Stock Ahead of Its Earnings? - Trefis
Hims & Hers Health Insider Sold Shares Worth $3,077,070, According to a Recent SEC Filing - marketscreener.com
Where Is Hims & Hers Stock Headed After Wegovy Tie-Up? Retail Traders Bet On Rebound To Over 2-Month High - MSN
Why Hims & Hers Health, Inc. (HIMS) Soared on Tuesday - MSN
Buy Hims (HIMS) or Novo Nordisk (NVO) Stock After Partnership Announcement? - Yahoo Finance
Hims & Hers vs. Teladoc: Which Telehealth Stock Is the Better Buy Now? - Nasdaq
Hims & Hers Health (HIMS) Stock: Weight Loss Drug Deal Sends Shares Soaring - MoneyCheck
Hims & Hers Health (HIMS) Stock Jumps 23.0%: Will It Continue to Soar? - Nasdaq
Hims Hers Health Inc (HIMS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.19%
0.42%
자본화:
|
볼륨(24시간):